Comparing treatments for early missed abortion
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study compares different treatment methods for early missed abortion (when a pregnancy ends but the tissue doesn't pass on its own) to see which works best in real-world settings. It may help you and your doctor choose the safest and most effective option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 40 years old.
- You have been diagnosed with an early missed abortion (the pregnancy stopped growing but hasn't passed).
- Your routine blood tests and health checks are normal, and you don't have serious diseases like heart, liver, or kidney problems.
- You are not currently having heavy vaginal bleeding that needs emergency treatment.
- You are willing to come back for checkups as planned.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different medicines (given vaginally or by mouth) to help complete a miscarriage or missed abortion in the first weeks of pregnancy. It aims to find which method works better and is safer for women.
This study compares two ways of taking the abortion pill misoprostol to find out which is more effective and acceptable for people ending an early pregnancy (up to 11 weeks). You would receive standard care and help doctors learn how to improve early abortion options.
This trial compares two different medication approaches to help your body complete a silent miscarriage, rather than needing surgery. One uses a hormone-balancing pill (letrozole) and the other uses a combination of two medicines (mifepristone and misoprostol). The goal is to find which is more effective and safer for you.
This study looks at pregnancy complications and outcomes after someone has an induced abortion in early pregnancy. It may help doctors better understand what to watch for in future pregnancies and how to reduce risks.
This trial tests two different medicines (Mifepristone vs Misoprostol) to see which works better for ending a pregnancy in the second trimester (12–16 weeks). It is for people who are pregnant with one baby and have no major health issues that could affect safety.
This study compares two approaches for managing retained pregnancy tissue (leftover tissue in the uterus after a medical abortion): waiting to see if your body passes it naturally versus taking medication to help remove it. The goal is to find out which approach works better and is safer for patients.
Hear when a new Missed Abortion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.